Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Control Group (people without a recent stroke):
- People aged 18 or older
- People who have never had a stroke, or whose last stroke was more than 3 years ago
- People with little to no lasting disability from any previous stroke (confirm with trial site)
- People who are outpatients at the Department of Neurology at the University Hospital of Zurich (USZ)
- Both the patient and their caregiver or close relative must be able to give informed consent
- Both the patient and their caregiver or close relative must be willing to take part
Main Group (people who have recently had a stroke or related event):
- People aged 18 or older who have been diagnosed with a transient ischemic attack (a brief, temporary disruption of blood flow to the brain), an ischemic stroke (a stroke caused by a blocked blood vessel), or an intracerebral hemorrhage (a stroke caused by bleeding in the brain)
- Caregivers of patients in the main group, aged 18 or older, may also be eligible to participate
- Patients who are either admitted to hospital or attending as outpatients at the University Hospital of Zurich (USZ), enrolled within 28 days of their stroke or related event
- Both the patient and their caregiver must be able to give informed consent
- Both the patient and their caregiver must be willing to take part
Who may not be able to join:
- People (in either group) who have taken steroid hormone medications — such as prednisone, prednisolone, dexamethasone, methylprednisolone, or hydrocortisone — at any point in the last 3 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Susanne Wegener, MD, University of Zurich
Phone: +41442551111
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Quality of Life as assessed via Short Form - 36 (SF-36)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.